Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 09 05 2019
accepted: 02 02 2020
entrez: 14 2 2020
pubmed: 14 2 2020
medline: 10 5 2020
Statut: epublish

Résumé

Acute coronary syndrome (ACS) patients with diabetes have significantly worse cardiovascular outcomes than those without diabetes. This study aimed to compare the performance of The Thrombolysis In Myocardial Infarction (TIMI), Global Registry of Acute Coronary Events (GRACE), Primary Angioplasty in Myocardial Infarction (PAMI), and Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) risk scores in predicting long-term cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction (STEMI). From the Acute Coronary Syndrome-Diabetes Mellitus Registry of the Taiwan Society of Cardiology, patients with STEMI were included. The TIMI, GRACE, PAMI, and CADILLAC risk scores were calculated. The discriminative potential of risk scores was analyzed using the area under the receiver-operating characteristics curve (AUC). In the 455 patients included, all four risk score systems demonstrated predictive accuracy for 6-, 12- and 24-month mortality with AUC values of 0.67-0.82. The CADILLAC score had the best discriminative accuracy, with an AUC of 0.8207 (p<0.0001), 0.8210 (p<0.0001), and 0.8192 (p<0.0001) for 6-, 12-, and 24-month mortality, respectively. It also had the best predictive value for bleeding and acute renal failure, with an AUC of 0.7919 (p<0.05) and 0.9764 (p<0.0001), respectively. Patients with CADILLAC risk scores >8 had poorer 2-year survival than those with lower scores (log-rank p<0.0001). In conclusion, the CADILLAC risk score is more effective than other risk scores in predicting 6-month, 1-year, and 2-year all-cause mortality in diabetic patients with STEMI. It also had the best predictive value for in-hospital bleeding and acute renal failure.

Identifiants

pubmed: 32053694
doi: 10.1371/journal.pone.0229186
pii: PONE-D-19-13226
pmc: PMC7018102
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0229186

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2011 Apr 27;305(16):1677-84
pubmed: 21521849
J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39
pubmed: 19007588
Radiology. 1983 Sep;148(3):839-43
pubmed: 6878708
J Am Coll Cardiol. 2010 Jul 20;56(4):254-63
pubmed: 20633817
Circulation. 2012 Oct 16;126(16):2020-35
pubmed: 22923432
Korean Circ J. 2018 Feb;48(2):134-147
pubmed: 29441746
Eur Heart J. 2006 Oct;27(19):2285-93
pubmed: 16908490
JAMA. 2007 May 2;297(17):1892-900
pubmed: 17473299
Acta Cardiol Sin. 2016 Jan;32(1):31-8
pubmed: 27171367
World J Diabetes. 2015 Oct 10;6(13):1246-58
pubmed: 26468341
Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28
pubmed: 23443340
PLoS One. 2015 Apr 20;10(4):e0123215
pubmed: 25893501
J Am Heart Assoc. 2013 Jan 29;2(1):e003269
pubmed: 23525425
JAMA. 2004 Jun 9;291(22):2727-33
pubmed: 15187054
Am J Med. 2011 Jan;124(1):40-7
pubmed: 21187184
Am J Cardiol. 2013 Jan 1;111(1):12-20
pubmed: 23040595
Am J Cardiol. 2017 Jun 15;119(12):1917-1923
pubmed: 28427734
J Am Coll Cardiol. 2005 May 3;45(9):1397-405
pubmed: 15862409
J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66
pubmed: 20513595
J Am Coll Cardiol. 2001 Dec;38(7):2114-30
pubmed: 11738323
Am J Epidemiol. 1982 Jan;115(1):92-106
pubmed: 7055134
Am J Cardiol. 2008 Jul 1;102(1):6-11
pubmed: 18572028
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Acta Cardiol Sin. 2018 May;34(3):211-223
pubmed: 29844642
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
Eur J Cardiovasc Nurs. 2013 Aug;12(4):330-6
pubmed: 22694809
Int J Cardiol. 2011 Apr 1;148(1):70-5
pubmed: 19923016

Auteurs

Yung-Ta Kao (YT)

Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Yi-Chen Hsieh (YC)

PhD Program of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
PhD Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Master Program in Applied Molecular Epidemiology, College of Public Health, Taipei Medical University, Taipei, Taiwan.

Chien-Yi Hsu (CY)

Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Chun-Yao Huang (CY)

Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Ming-Hsiung Hsieh (MH)

Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan.

Yung-Kuo Lin (YK)

Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan.

Jong-Shiuan Yeh (JS)

Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH